Share on StockTwits

Investment analysts at Wells Fargo & Co. began coverage on shares of Qiagen N.V. (NASDAQ:QGEN) in a note issued to investors on Wednesday, reports. The firm set a “market perform” rating on the stock.

Several other analysts have also recently commented on the stock. Analysts at Zacks reiterated a “neutral” rating on shares of Qiagen N.V. in a research note on Tuesday. They now have a $26.00 price target on the stock. Analysts at HSBC upgraded shares of Qiagen N.V. from an “underweight” rating to a “neutral” rating in a research note on Tuesday, May 13th. They now have a $23.33 price target on the stock, up previously from $21.88. One investment analyst has rated the stock with a sell rating, eight have given a hold rating and three have given a buy rating to the stock. Qiagen N.V. has a consensus rating of “Hold” and a consensus price target of $24.22.

Shares of Qiagen N.V. (NASDAQ:QGEN) traded up 0.12% on Wednesday, hitting $24.56. 698,263 shares of the company’s stock traded hands. Qiagen N.V. has a 52-week low of $19.46 and a 52-week high of $24.83. The stock’s 50-day moving average is $23.5 and its 200-day moving average is $22.51. The company has a market cap of $5.725 billion and a price-to-earnings ratio of 116.26.

Qiagen N.V. (NASDAQ:QGEN) last released its earnings data on Wednesday, May 7th. The company reported $0.22 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.22. The company had revenue of $317.40 million for the quarter, compared to the consensus estimate of $317.09 million. During the same quarter in the previous year, the company posted $0.23 earnings per share. The company’s revenue for the quarter was up 4.5% on a year-over-year basis. Analysts expect that Qiagen N.V. will post $1.08 EPS for the current fiscal year.

QIAGEN N.V., (NASDAQ:QGEN) is a holding company, which provides sample and assay technologies.

The Fly On The Wall

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.